Registration is now open for the 18th Seminar of HITRIplus – “Minibeam Radiation Therapy: From Concept to Clinical Application“, scheduled for November 11 (from 17:00 to 18:00). The seminar will be given by Yolanda Prezado, Institut Curie and Michael Grams, Mayo Clinic.

Yolanda Prezado is a research professor at the Centre for Research in Molecular Medicina and Chronic Diseases (CiMUS), in Spain and a senior researcher at the Institut Curie (France).  She is  a research director at the French National Center for Scientific Research (CNRS) (on leave) and head of the interdisciplinary team New Approaches in Radiotherapy (NARA). She has a multidisciplinary background. Her main research focus is spatially fractionated radiation therapy and proton therapy. One of their main projects is proton minibeam radiation therapy, funded by the European Union via an ERC consolidator grant. She has been the chair of the European Federation of Medical Physicists scientific committee from 2019 to 2021 and is the deputy spokesperson of the International Biophysics Collaboration. She has served on many committees and working groups.  Her work in proton therapy has been rewarded with the Mr et Mme Peyre prize of the French Academy of Sciences in 2021.

Michael Grams, PhD is a board-certified medical physicist, associate professor, and researcher at the Mayo Clinic in Rochester, Minnesota, USA. He collaborated with physician colleagues and started the spatially fractionated radiation therapy (SFRT) program at Mayo Clinic in 2019. He is the lead physicist responsible for all aspects of this treatment, and Mayo currently treats more than 100 patients per year with various forms of SFRT including lattice, grid, and minibeam techniques. His current research and clinical focus is on the physics and biology of minibeam radiation therapy (MBRT) and his overarching goal is to utilize the unique features of MBRT to improve outcomes for cancer patients.

For more information: https://indico.cern.ch/event/1468364/